JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M414215200 on June 21, 2005

J. Biol. Chem., Vol. 280, Issue 33, 29708-29716, August 19, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/33/29708    most recent
M414215200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yuan, H.
Right arrow Articles by Traynelis, S. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yuan, H.
Right arrow Articles by Traynelis, S. F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Conserved Structural and Functional Control of N-Methyl-D-aspartate Receptor Gating by Transmembrane Domain M3*

Hongjie Yuan{ddagger}, Kevin Erreger, Shashank M. Dravid, and Stephen F. Traynelis

From the Department of Pharmacology, Emory University School of Medicine, Rollins Research Center, Atlanta, Georgia 30322-3090

The molecular events controlling glutamate receptor ion channel gating are complex. The movement of transmembrane domain M3 within N-methyl-D-aspartate (NMDA) receptor subunits has been suggested to be one structural determinant linking agonist binding to channel gating. Here we report that covalent modification of NR1-A652C or the analogous mutation in NR2A, -2B, -2C, or -2D by methanethiosulfonate ethylammonium (MT-SEA) occurs only in the presence of glutamate and glycine, and that modification potentiates recombinant NMDA receptor currents. The modified channels remain open even after removing glutamate and glycine from the external solution. The degree of potentiation depends on the identity of the NR2 subunit (NR2A < NR2B < NR2C,D) inversely correlating with previous measurements of channel open probability. MTSEA-induced modification of channels is associated with increased glutamate potency, increased mean single-channel open time, and slightly decreased channel conductance. Modified channels are insensitive to the competitive antagonists D-2-amino-5-phosphonovaleric acid (APV) and 7-Cl-kynurenic acid, as well as allosteric modulators of gating (extracellular protons and Zn2+). However, channels remain fully sensitive to Mg2+ blockade and partially sensitive to pore block by (+)MK-801, (-)MK-801, ketamine, memantine, amantadine, and dextrorphan. The partial sensitivity to (+)MK-801 may reflect its ability to stimulate agonist unbinding from MT-SEA-modified receptors. In summary, these data suggest that the SYTANLAAF motif within M3 is a conserved and critical determinant of channel gating in all NMDA receptors.


Received for publication, December 17, 2004 , and in revised form, June 20, 2005.

* This work was supported by grants from the NINDS, National Institutes of Health (to S. F. T.), National Alliance for Research on Schizophrenia and Depression (to S. F. T.), and the Howard Hughes Medical Institute (to K. E.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} To whom correspondence should be addressed: Dept. of Pharmacology, Emory University School of Medicine, Rollins Research Center, 1510 Clifton Rd., Atlanta, GA 30322-3090. Tel.: 404-727-1375; Fax: 404-727-0365; E-mail: hyuan{at}emory.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
M. L. Blanke and A. M. J. VanDongen
The NR1 M3 Domain Mediates Allosteric Coupling in the N-Methyl-D-aspartate Receptor
Mol. Pharmacol., August 1, 2008; 74(2): 454 - 465.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
H. U. Weigt, O. Adolph, M. Georgieff, E. M. Georgieff, and K. J. Fohr
Evidence That Xenon Does Not Produce Open Channel Blockade of the NMDA Receptor
J Neurophysiol, April 1, 2008; 99(4): 1983 - 1987.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H.-R. Chang and C.-C. Kuo
The Activation Gate and Gating Mechanism of the NMDA Receptor
J. Neurosci., February 13, 2008; 28(7): 1546 - 1556.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. M. Schmid, C. Korber, S. Herrmann, M. Werner, and M. Hollmann
A Domain Linking the AMPA Receptor Agonist Binding Site to the Ion Pore Controls Gating and Causes lurcher Properties when Mutated
J. Neurosci., November 7, 2007; 27(45): 12230 - 12241.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. Erreger, M. T. Geballe, A. Kristensen, P. E. Chen, K. B. Hansen, C. J. Lee, H. Yuan, P. Le, P. N. Lyuboslavsky, N. Micale, et al.
Subunit-Specific Agonist Activity at NR2A-, NR2B-, NR2C-, and NR2D-Containing N-Methyl-D-aspartate Glutamate Receptors
Mol. Pharmacol., October 1, 2007; 72(4): 907 - 920.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
H.-R. Chang and C.-C. Kuo
Extracellular Proton-Modulated Pore-Blocking Effect of the Anticonvulsant Felbamate on NMDA Channels
Biophys. J., September 15, 2007; 93(6): 1981 - 1992.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Physiol.Home page
A. I. Sobolevsky, M. L. Prodromou, M. V. Yelshansky, and L. P. Wollmuth
Subunit-specific Contribution of Pore-forming Domains to NMDA Receptor Channel Structure and Gating
J. Gen. Physiol., June 1, 2007; 129(6): 509 - 525.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. M. Dravid, K. Erreger, H. Yuan, K. Nicholson, P. Le, P. Lyuboslavsky, A. Almonte, E. Murray, C. Mosley, J. Barber, et al.
Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block
J. Physiol., May 15, 2007; 581(1): 107 - 128.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Jin, H. Sugiyama, M. Takigawa, D. Katagiri, H. Tomitori, K. Nishimura, N. Kaur, O. Phanstiel IV, M. Kitajima, H. Takayama, et al.
Comparative Studies of Anthraquinone- and Anthracene-Tetraamines as Blockers of N-Methyl-D-aspartate Receptors
J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 47 - 55.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.